Cargando…

Blood type A associated with critical COVID-19 and death in a Swedish cohort—a critical comment

Detalles Bibliográficos
Autor principal:	Bullerdiek, Joern
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472394/ https://www.ncbi.nlm.nih.gov/pubmed/32887647 http://dx.doi.org/10.1186/s13054-020-03264-z

Ejemplares similares

Blood type A associates with critical COVID-19 and death in a Swedish cohort
por: Hultström, Michael, et al.
Publicado: (2020)

Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
por: Asif, Sana, et al.
Publicado: (2020)

Causes and timing of death in critically ill COVID-19 patients
por: Contou, Damien, et al.
Publicado: (2021)

COVID-19 challenging cell biology
por: Bullerdiek, Joern
Publicado: (2020)

Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection
por: Corrêa, Thiago Domingos, et al.
Publicado: (2020)

Comments on "A critical review of epidemiologic studies of radiofrequency exposure and human cancers".
por: Hocking, B
Publicado: (1999)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
por: Champion, Sébastien
Publicado: (2015)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
por: Jelliffe, Roger
Publicado: (2016)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Peripheral Blood Smears in COVID-19: A Comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Blood volume and albumin transudation in critically ill COVID-19 patients
por: Bakker, Jan, et al.
Publicado: (2021)

The critical role of complete blood count in the management of patients with COVID-19
por: Ahnach, Maryame, et al.
Publicado: (2020)

The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
por: Järhult, Josef D., et al.
Publicado: (2021)

Clinical and conceptual comments on “Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis”
por: Jayaraj, Rama, et al.
Publicado: (2020)

Response to “Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis”
por: Nieuwenhuis, Marieke B., et al.
Publicado: (2020)

Response to: Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
por: Arrigo, Mattia, et al.
Publicado: (2016)

Lithium and renal tumors: a critical comment to the report by Zaidan et al.
por: Licht, Rasmus W, et al.
Publicado: (2014)

Functional status of recovered critical COVID-19 patients: An assessment of a convalescent cohort
por: Sousa, L., et al.
Publicado: (2022)

Functional status of recovered critical COVID-19 patients: An assessment of a convalescent cohort
por: Sousa, L., et al.
Publicado: (2022)

COVID-19 Associated Dysautonomia in a Non-Critically Ill COVID-19 Patient
por: Abdelnabi, Mahmoud, et al.
Publicado: (2021)

Some Comments and a Criticism
Publicado: (1920)

Association of Obesity With More Critical Illness in COVID-19
por: Sharma, Abhishek, et al.
Publicado: (2020)

Micronutrient status of COVID-19 patients: a critical consideration
por: Carr, Anitra C.
Publicado: (2020)

ECG pathology and its association with death in critically ill COVID-19 patients, a cohort study
por: Rosén, Jacob, et al.
Publicado: (2021)

Infectious SARS-CoV-2 is rarely present in the nasopharynx samples collected from Swedish hospitalized critically ill COVID-19 patients
por: Ling, Jiaxin, et al.
Publicado: (2022)

Endocrine emergencies in critically-ill patients: Challenges in diagnosis and management: Comment
por: Shanbag, Preeti
Publicado: (2013)

Comments on “Candida glabrata candidemia; an emerging threat in critically ill patients”
por: Ahmed, Armin, et al.
Publicado: (2015)

Critical Comment on Depression in Main Caregivers of Dementia Patients: Prevalence and Predictors
por: Saini, Radha, et al.
Publicado: (2018)

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis
por: Verroken, Alexia, et al.
Publicado: (2020)

Comment on “A retrospective analysis: the outcome of renal replacement therapies in critically ill children”
por: Zhao, Qinqin, et al.
Publicado: (2023)

Reassessing the death risk related to probiotics in critically ill patients
por: Maraolo, Alberto Enrico
Publicado: (2016)

Association of Chronic Critical Illness and COVID-19 in Patients Admitted to Intensive Care Units: A Prospective Cohort Study
por: Pérez-Anibal, Eduard, et al.
Publicado: (2023)

Organizational aspects of care associated with mortality in critically ill COVID-19 patients
por: Rimmelé, Thomas, et al.
Publicado: (2020)

Immune characteristics of severe and critical COVID-19 patients
por: Yang, Li, et al.
Publicado: (2020)

Clinical phenotypes of critically ill COVID-19 patients
por: Azoulay, Elie, et al.
Publicado: (2020)

Critical Illness Polyneuropathy as a Sequelae of COVID-19
por: Bawiskar, Nipun, et al.
Publicado: (2022)

COVID-19 mortality in ICUs associated with critical care staffing
por: Xi, Jingjing, et al.
Publicado: (2021)

Comment on “Association-19 of body mass index with COVID-19 related in-hospital death” Clinical Nutrition 2022
por: Santos de Sousa Fernandes, Matheus, et al.
Publicado: (2022)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Response to “Reassessing the death risk related to probiotics in critically ill patients”
por: Manzanares, William, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d9er6f7d544bi8i08repa4kpe5